Xeriant, Inc.
XERI· OTC
XERIXeriant, Inc.
Filed Nov 13, 2023 · 10-Q · 44 days after period end · 0001477932-23-008302
| Metric | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|
| Net Income | -$342.01K | -$4.82M | -$4.45M | -$327.07K |
| EPS Diluted | — | -$0.01 | -$0.02 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Xeriant, Inc. · CIK 1481504 · Engraved from SEC EDGAR
ended Sep 30, 2023 · filed Nov 13, 2023 · 44 d after period end
